NO995039D0 - Gastric retained pharmaceutical preparation - Google Patents

Gastric retained pharmaceutical preparation

Info

Publication number
NO995039D0
NO995039D0 NO995039A NO995039A NO995039D0 NO 995039 D0 NO995039 D0 NO 995039D0 NO 995039 A NO995039 A NO 995039A NO 995039 A NO995039 A NO 995039A NO 995039 D0 NO995039 D0 NO 995039D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
gastric retained
retained pharmaceutical
gastric
preparation
Prior art date
Application number
NO995039A
Other languages
Norwegian (no)
Other versions
NO995039L (en
Inventor
Jerome Besse
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995039D0 publication Critical patent/NO995039D0/en
Publication of NO995039L publication Critical patent/NO995039L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
NO995039A 1997-04-18 1999-10-15 Gastric retained pharmaceutical preparation NO995039L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (en) 1997-04-18 1997-04-18 PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION
PCT/FR1998/000755 WO1998047506A1 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO995039D0 true NO995039D0 (en) 1999-10-15
NO995039L NO995039L (en) 1999-12-17

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995039A NO995039L (en) 1997-04-18 1999-10-15 Gastric retained pharmaceutical preparation

Country Status (19)

Country Link
EP (1) EP0983065A1 (en)
JP (1) JP2001523241A (en)
KR (1) KR20010006353A (en)
CN (1) CN1252720A (en)
AR (1) AR015586A1 (en)
AU (1) AU737634B2 (en)
CA (1) CA2286081A1 (en)
FR (1) FR2762213B1 (en)
HU (1) HUP0002455A3 (en)
IL (1) IL131995A0 (en)
JO (1) JO2017B1 (en)
MA (1) MA26482A1 (en)
NO (1) NO995039L (en)
NZ (1) NZ500288A (en)
PE (1) PE68199A1 (en)
PL (1) PL336273A1 (en)
TN (1) TNSN98049A1 (en)
WO (1) WO1998047506A1 (en)
ZA (1) ZA983258B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (en) 1998-10-16 2002-01-25 Synthelabo PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE AND CONTROLLED RELEASE
FR2790388B1 (en) * 1999-03-04 2001-04-13 Synthelabo PHARMACEUTICAL COMPOSITIONS COMPRISING A BENZAMIDE AND AT LEAST ONE ABSORPTION PROMOTER
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2009157711A2 (en) * 2008-06-24 2009-12-30 Park Eun-Seok Gastro-retentive porous tablet and method for preparing same
FR2949061B1 (en) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma FLOATING MICROGRANULES
SI2719376T1 (en) 2012-10-12 2015-06-30 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
MX2020005517A (en) 2017-12-05 2020-11-09 Sunovion Pharmaceuticals Inc Crystal forms and production methods thereof.
US10369134B2 (en) 2017-12-05 2019-08-06 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
JP7044649B2 (en) * 2018-06-28 2022-03-30 株式会社ファンケル Intragastric floating tablets
KR20220018004A (en) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 Controlled release formulations and uses thereof
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (en) * 1978-01-20 1979-08-17 Ile De France NEW DERIVATIVES OF 4-AMINO-5-ALKYLSULFONYL ORTHO-ANISAMIDES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION AS PSYCHOTROPES
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
JPS62178518A (en) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk Novel long-acting sulpiride tablet
JPH0776172B2 (en) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 Matrice locks
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials

Also Published As

Publication number Publication date
AU737634B2 (en) 2001-08-23
EP0983065A1 (en) 2000-03-08
PE68199A1 (en) 1999-07-15
MA26482A1 (en) 2004-12-20
FR2762213A1 (en) 1998-10-23
FR2762213B1 (en) 1999-05-14
NZ500288A (en) 2001-03-30
AU7341698A (en) 1998-11-13
JO2017B1 (en) 1999-05-15
JP2001523241A (en) 2001-11-20
HUP0002455A2 (en) 2000-12-28
ZA983258B (en) 1998-10-19
HUP0002455A3 (en) 2001-01-29
CA2286081A1 (en) 1998-10-29
NO995039L (en) 1999-12-17
KR20010006353A (en) 2001-01-26
TNSN98049A1 (en) 2005-03-15
WO1998047506A1 (en) 1998-10-29
PL336273A1 (en) 2000-06-19
AR015586A1 (en) 2001-05-16
CN1252720A (en) 2000-05-10
IL131995A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
NO20001612D0 (en) Oral preparation
NO973612D0 (en) New pharmaceutical preparation
NO20001776L (en) drugs
NO20005399L (en) Pharmaceutical preparation
NO996372D0 (en) Solid pharmaceutical preparation containing benzofuan derivatives
NO20001160L (en) New foam-forming pharmaceutical preparation
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
NO943888D0 (en) Pharmaceutical preparation
IS4974A (en) Pressure-spray pharmaceutical composition
NO983624D0 (en) Solid biocidal preparation
NO994003D0 (en) Pharmaceutical blend
DK1466615T3 (en) Pharmaceutical preparation
NO20015149D0 (en) New pharmaceutical preparation
DK1017392T3 (en) Medicines
NO995039L (en) Gastric retained pharmaceutical preparation
NO20015148D0 (en) New pharmaceutical preparation
NO973610D0 (en) New pharmaceutical preparation
ID29294A (en) PHARMACEUTICAL COMPOSITION
ID25857A (en) PHARMACEUTICAL COMPOSITION
NO20015104D0 (en) New pharmaceutical preparation
NO973611D0 (en) New pharmaceutical preparation
NO950950D0 (en) Pharmaceutical preparation
NO20015105L (en) New pharmaceutical preparation
NO20021036L (en) Pharmaceutical preparation
ID23531A (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application